Skymax Laboratories Limited, a active public limited company, was established on 11 November 1993 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24230GJ1993PLC020662. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.
Formerly known as Skymax Laboratories P Limited. It upholds a active non-compliant status. Its leadership includes Anilkumar Rasiklal Patel (Director), Rasiklal Parsottam Kadivar (Director), Rajiv Jivanbhai Parmar (Additional Director). Past directors included Rakeshkumar Mansukhlal Patel, Uttamkumar Rasiklal Javia, Chirag Jamanbhai Dadhania. It holds ₹8.06 M open charges and ₹5.55 Cr settled loans. Its latest AGM occurred on 19 August 2013, with the balance sheet filed on 31 March 2011. It is based at B-206, Shapath 4, Opp. Karnavati Club, S.G. Highway,, Ahmedabad, Gujarat, 380051.
U24230GJ1993PLC020662
020662
11 November 1993
₹1.00 Cr
₹1.00 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Skymax Laboratories Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anilkumar Rasiklal Patel | Director | 11 Nov 1993 | Current |
| Rasiklal Parsottam Kadivar | Director | 06 Jun 2005 | Current |
| Rajiv Jivanbhai Parmar | Additional Director | 28 Jun 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 27 Sep 2007 | Past |
| Pramod Abcsdd | Director | 27 Sep 2007 | Past |
| Pramod Abcsdd | Director | 29 Jun 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Skymax Laboratories's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Skymax Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹8,064,500.00
₹55,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Nov 2008 | Dena Bank | ₹8.00 M | Open |
| 13 Oct 1995 | State Bank Of Saurashtra | ₹0.06 M | Open |
| 05 Apr 2006 | Hdfc Bank Limited | ₹2.75 Cr | Satisfied |
| 04 Oct 2004 | Karnataka Bank Ltd. | ₹1.40 Cr | Satisfied |
| 12 Jul 1999 | Karnataka Bank Ltd. | ₹1.40 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Skymax Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Skymax Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skymax Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Rajiv Jivanbhai Parmar was appointed as a Additional Director was appointed as a Additional Director on 28 Jun 2018 & has been associated with this company since 7 years 5 months . was documented.
Progress on Skymax Laboratories Limited last Annual general meeting of members was held on 19 Aug 2013 as per latest MCA records. was documented.
The activity Skymax Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2011 with Roc Ahmedabad. was completed.
Progress on A charge with Dena Bank of Rs. 0.80 Cr registered on 27 Nov 2008 with Charge ID 10133847 was modified on 28 Dec 2010. was documented.
The activity A charge with Dena Bank amounted to Rs. 0.80 Cr with Charge ID 10133847 was registered on 27 Nov 2008. was completed.
Progress on A charge registered on 05 Apr 2006 via Charge ID 80039490 with Hdfc Bank Limited was fully satisfied on 16 Nov 2007. was documented.
The CIN of Skymax Laboratories Limited is U24230GJ1993PLC020662.
Skymax Laboratories Limited is headquartered at B-206, Shapath 4, Opp. Karnavati Club, S.G. Highway,, Ahmedabad, Gujarat, 380051.
Skymax Laboratories Limited was incorporated on 11 November 1993.
The current directors of Skymax Laboratories Limited are
The primary industry of Skymax Laboratories Limited is Pharma.
Skymax Laboratories Limited is unlisted.
The authorized capital of Skymax Laboratories Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.
The compliance status of Skymax Laboratories Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX